Portfolio Holdings Detail for ISIN IE00BD93YH54
Stock Name / Fund iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF Ticker SPMD(USD) LSE
ETF Ticker SPMD.LS(USD) CXE
ETF Ticker SPMD.L(GBP) LSE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-03 (Wednesday)	8,155	USD 5,901,529	USD 5,901,529	0	USD -149,481	USD 723.67	USD 742
2025-12-02 (Tuesday)	8,155	USD 6,051,010	USD 6,051,010	0	USD -66,137	USD 742	USD 750.11
2025-12-01 (Monday)	8,155	USD 6,117,147	USD 6,117,147	0	USD -245,302	USD 750.11	USD 780.19
2025-11-28 (Friday)	8,155	USD 6,362,449	USD 6,362,449	0	USD -36,046	USD 780.19	USD 784.61
2025-11-27 (Thursday)	8,155	USD 6,398,495	USD 6,398,495	0	USD 0	USD 784.61	USD 784.61
2025-11-26 (Wednesday)	8,155	USD 6,398,495	USD 6,398,495	209	USD 142,450	USD 784.61	USD 787.32
2025-11-25 (Tuesday)	7,946	USD 6,256,045	USD 6,256,045	44	USD 239,067	USD 787.32	USD 761.45
2025-11-24 (Monday)	7,902	USD 6,016,978	USD 6,016,978	33	USD 68,801	USD 761.45	USD 755.9
2025-11-21 (Friday)	7,869	USD 5,948,177	USD 5,948,177	22	USD 164,938	USD 755.9	USD 737
2025-11-20 (Thursday)	7,847	USD 5,783,239	USD 5,783,239	44	USD 299,681	USD 737	USD 702.75
2025-11-19 (Wednesday)	7,803	USD 5,483,558	USD 5,483,558	0	USD -176,270	USD 702.75	USD 725.34
2025-11-18 (Tuesday)	7,803	USD 5,659,828	USD 5,659,828	0	USD 164,097	USD 725.34	USD 704.31
2025-11-17 (Monday)	7,803	USD 5,495,731	USD 5,495,731	0	USD 84,350	USD 704.31	USD 693.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BD93YH54

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-26 BUY 209 790.980 777.000 778.398 USD 162,685 647.15
2025-11-26 BUY 209 790.980 777.000 778.398 USD 162,685 647.15
2025-11-25 BUY 44 790.570 760.700 763.687 USD 33,602 646.44
2025-11-24 BUY 33 773.130 756.640 758.289 USD 25,024 645.85
2025-11-21 BUY 22 755.900* 645.29
2025-11-20 BUY 44 737.000* 644.81
2025-11-11 BUY 154 676.330 651.410 653.902 USD 100,701 642.87
2025-11-10 SELL -154 665.990 653.190 654.470 USD -100,788 642.81 Loss of -1,796 on sale
2025-11-07 SELL -132 657.530* 642.73 Profit of 84,840 on sale
2025-11-06 BUY 132 657.000 641.260 642.834 USD 84,854 642.70
2025-11-04 SELL -11 646.221 625.140 627.248 USD -6,900 642.78 Profit of 171 on sale
2025-10-27 BUY 44 585.310 586.150 586.066 USD 25,787 642.87
2025-10-22 SELL -22 584.740 588.710 588.313 USD -12,943 643.97 Profit of 1,224 on sale
2025-10-20 BUY 66 576.770 582.650 582.062 USD 38,416 644.74
2025-10-15 SELL -44 576.420 584.870 584.025 USD -25,697 645.99 Profit of 2,727 on sale
2025-10-14 BUY 22 572.600 576.180 575.822 USD 12,668 646.43
2025-10-03 BUY 22 600.000 618.010 616.209 USD 13,557 646.71
2025-09-30 BUY 11 562.270 574.040 572.863 USD 6,301 647.80
2025-09-25 BUY 11 555.510 579.000 576.651 USD 6,343 649.45
2025-07-16 SELL -390 547.930 558.350 557.308 USD -217,350 653.72 Profit of 37,599 on sale
2025-07-14 SELL -52 570.590 575.130 574.676 USD -29,883 654.98 Profit of 4,176 on sale
2025-07-11 SELL -78 567.740 568.460 568.388 USD -44,334 655.56 Profit of 6,800 on sale
2025-07-10 SELL -26 559.760 566.370 565.709 USD -14,708 656.21 Profit of 2,353 on sale
2025-07-09 SELL -52 552.580 558.380 557.800 USD -29,006 656.91 Profit of 5,154 on sale
2025-07-03 SELL -390 547.360 555.000 554.236 USD -216,152 657.66 Profit of 40,337 on sale
2025-07-02 SELL -50 547.740 551.500 551.124 USD -27,556 658.42 Profit of 5,365 on sale
2025-06-27 SELL -52 521.000 531.210 530.189 USD -27,570 660.32 Profit of 6,767 on sale
2025-06-23 SELL -52 511.920 516.180 515.754 USD -26,819 664.39 Profit of 7,729 on sale
2025-06-20 SELL -26 509.720 521.310 520.151 USD -13,524 665.51 Profit of 3,779 on sale
2025-06-18 SELL -50 513.580 519.170 518.611 USD -25,931 667.74 Profit of 7,457 on sale
2025-06-16 SELL -312 522.680 538.200 536.648 USD -167,434 670.01 Profit of 41,609 on sale
2025-06-13 SELL -1,278 529.240 529.550 529.519 USD -676,725 671.07 Profit of 180,900 on sale
2025-06-12 SELL -1,151 521.840 525.220 524.882 USD -604,139 672.20 Profit of 169,562 on sale
2025-06-11 SELL -52 518.600 528.370 527.393 USD -27,424 673.37 Profit of 7,591 on sale
2025-06-06 BUY 78 493.220 499.880 499.214 USD 38,939 677.17
2025-06-05 BUY 104 483.070 491.770 490.900 USD 51,054 678.69
2025-05-28 SELL -78 591.850 606.000 604.585 USD -47,158 686.31 Profit of 6,374 on sale
2025-05-27 BUY 78 603.260 608.170 607.679 USD 47,399 687.00
2025-05-23 SELL -234 588.340 591.640 591.310 USD -138,367 688.67 Profit of 22,782 on sale
2025-05-22 BUY 52 596.850 605.500 604.635 USD 31,441 689.46
2025-05-20 BUY 234 614.790 615.450 615.384 USD 144,000 690.84
2025-05-16 BUY 99 594.320 595.190 595.103 USD 58,915 692.53
2025-05-15 BUY 100 584.990 585.260 585.233 USD 58,523 693.49
2025-05-14 SELL -675 571.360 580.560 579.640 USD -391,257 694.59 Profit of 77,593 on sale
2025-05-13 BUY 50 574.160 575.050 574.961 USD 28,748 695.69
2025-05-12 BUY 125 575.630 577.990 577.754 USD 72,219 696.79
2025-05-09 SELL -100 527.780 552.840 550.334 USD -55,033 698.35 Profit of 14,802 on sale
2025-05-08 BUY 75 547.670 552.570 552.080 USD 41,406 699.76
2025-05-07 SELL -125 560.930 568.130 567.410 USD -70,926 701.07 Profit of 16,708 on sale
2025-04-30 SELL -25 598.760 600.200 600.056 USD -15,001 706.51 Profit of 2,661 on sale
2025-04-28 SELL -150 610.860 614.830 614.433 USD -92,165 708.86 Profit of 14,164 on sale
2025-04-23 BUY 25 587.850 603.770 602.178 USD 15,054 712.37
2025-04-15 BUY 325 557.910 575.200 573.471 USD 186,378 722.30
2025-04-14 BUY 50 571.060 574.720 574.354 USD 28,718 723.99
2025-04-09 SELL -150 576.720 580.730 580.329 USD -87,049 729.75 Profit of 22,413 on sale
2025-04-08 BUY 75 556.810 586.030 583.108 USD 43,733 731.78
2025-04-04 BUY 150 573.450 612.990 609.036 USD 91,355 735.60
2025-04-02 BUY 73 625.600 628.000 627.760 USD 45,826 736.95
2025-04-01 SELL -225 617.000 641.240 638.816 USD -143,734 738.43 Profit of 22,412 on sale
2025-03-31 BUY 1,184 634.230 640.720 640.071 USD 757,844 739.73
2025-03-28 BUY 150 637.360 642.970 642.409 USD 96,361 741.03
2025-03-27 BUY 294 635.830 643.430 642.670 USD 188,945 742.37
2025-03-26 BUY 748 640.140 644.000 643.614 USD 481,423 743.70
2025-03-25 BUY 513 634.140 662.570 659.727 USD 338,440 745.14
2025-03-24 SELL -75 661.000 667.460 666.814 USD -50,011 746.26 Profit of 5,959 on sale
2025-03-21 SELL -4,100 658.480 661.000 660.748 USD -2,709,067 747.45 Profit of 355,483 on sale
2025-03-19 BUY 91 672.360 674.570 674.349 USD 61,366 749.67
2025-03-17 SELL -188 678.420 679.830 679.689 USD -127,782 751.90 Profit of 13,576 on sale
2025-03-14 SELL -94 666.870 686.980 684.969 USD -64,387 753.13 Profit of 6,407 on sale
2025-03-13 SELL -94 680.610 698.950 697.116 USD -65,529 754.20 Profit of 5,366 on sale
2025-03-12 SELL -188 689.500 712.460 710.164 USD -133,511 755.16 Profit of 8,460 on sale
2025-03-07 BUY 282 707.510 729.750 727.526 USD 205,162 756.65
2025-02-28 BUY 282 698.740 708.580 707.596 USD 199,542 761.32
2025-02-26 BUY 376 706.940 721.410 719.963 USD 270,706 763.27
2025-02-21 BUY 564 700.330 704.080 703.705 USD 396,890 766.05
2025-02-18 BUY 188 680.000 689.950 688.955 USD 129,524 770.59
2025-02-11 BUY 470 665.460 680.790 679.257 USD 319,251 781.28
2025-02-07 BUY 188 710.000 731.420 729.278 USD 137,104 784.88
2025-02-06 BUY 94 722.070 734.270 733.050 USD 68,907 786.31
2025-02-05 BUY 282 716.720 729.250 727.997 USD 205,295 787.93
2025-02-04 BUY 94 697.050 709.980 708.687 USD 66,617 790.09
2025-01-31 SELL -188 672.980 688.000 686.498 USD -129,062 796.10 Profit of 20,605 on sale
2025-01-29 SELL -188 687.270 697.570 696.540 USD -130,950 801.94 Profit of 19,815 on sale
2025-01-02 SELL -557 715.190 726.810 725.648 USD -404,186 818.70 Profit of 51,829 on sale
2024-12-10 SELL -94 778.500 791.490 790.191 USD -74,278 819.95 Profit of 2,798 on sale
2024-12-09 SELL -94 788.000 800.990 799.691 USD -75,171 820.98 Profit of 2,002 on sale
2024-11-27 SELL -188 754.870 762.160 761.431 USD -143,149 842.54 Profit of 15,249 on sale
2024-11-21 SELL -376 744.500 757.560 756.254 USD -284,352 862.81 Profit of 40,066 on sale
2024-11-20 SELL -188 743.350 750.690 749.956 USD -140,992 869.45 Profit of 22,465 on sale
2024-11-18 SELL -188 762.000 762.700 762.630 USD -143,374 883.97 Profit of 22,812 on sale
2024-11-12 SELL -564 821.000 831.000 830.000 USD -468,120 888.17 Profit of 32,806 on sale
2024-11-08 SELL -1,504 828.420 830.730 830.499 USD -1,249,070 892.43 Profit of 93,151 on sale
2024-11-07 SELL -658 824.480 832.530 831.725 USD -547,275 897.66 Profit of 43,386 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-26	BUY	209	790.980	777.000	778.398	USD 162,685	647.15
2025-11-26	BUY	209	790.980	777.000	778.398	USD 162,685	647.15
2025-11-25	BUY	44	790.570	760.700	763.687	USD 33,602	646.44
2025-11-24	BUY	33	773.130	756.640	758.289	USD 25,024	645.85
2025-11-21	BUY	22			755.900*		645.29
2025-11-20	BUY	44			737.000*		644.81
2025-11-11	BUY	154	676.330	651.410	653.902	USD 100,701	642.87
2025-11-10	SELL	-154	665.990	653.190	654.470	USD -100,788	642.81 Loss of -1,796 on sale
2025-11-07	SELL	-132			657.530*		642.73 Profit of 84,840 on sale
2025-11-06	BUY	132	657.000	641.260	642.834	USD 84,854	642.70
2025-11-04	SELL	-11	646.221	625.140	627.248	USD -6,900	642.78 Profit of 171 on sale
2025-10-27	BUY	44	585.310	586.150	586.066	USD 25,787	642.87
2025-10-22	SELL	-22	584.740	588.710	588.313	USD -12,943	643.97 Profit of 1,224 on sale
2025-10-20	BUY	66	576.770	582.650	582.062	USD 38,416	644.74
2025-10-15	SELL	-44	576.420	584.870	584.025	USD -25,697	645.99 Profit of 2,727 on sale
2025-10-14	BUY	22	572.600	576.180	575.822	USD 12,668	646.43
2025-10-03	BUY	22	600.000	618.010	616.209	USD 13,557	646.71
2025-09-30	BUY	11	562.270	574.040	572.863	USD 6,301	647.80
2025-09-25	BUY	11	555.510	579.000	576.651	USD 6,343	649.45
2025-07-16	SELL	-390	547.930	558.350	557.308	USD -217,350	653.72 Profit of 37,599 on sale
2025-07-14	SELL	-52	570.590	575.130	574.676	USD -29,883	654.98 Profit of 4,176 on sale
2025-07-11	SELL	-78	567.740	568.460	568.388	USD -44,334	655.56 Profit of 6,800 on sale
2025-07-10	SELL	-26	559.760	566.370	565.709	USD -14,708	656.21 Profit of 2,353 on sale
2025-07-09	SELL	-52	552.580	558.380	557.800	USD -29,006	656.91 Profit of 5,154 on sale
2025-07-03	SELL	-390	547.360	555.000	554.236	USD -216,152	657.66 Profit of 40,337 on sale
2025-07-02	SELL	-50	547.740	551.500	551.124	USD -27,556	658.42 Profit of 5,365 on sale
2025-06-27	SELL	-52	521.000	531.210	530.189	USD -27,570	660.32 Profit of 6,767 on sale
2025-06-23	SELL	-52	511.920	516.180	515.754	USD -26,819	664.39 Profit of 7,729 on sale
2025-06-20	SELL	-26	509.720	521.310	520.151	USD -13,524	665.51 Profit of 3,779 on sale
2025-06-18	SELL	-50	513.580	519.170	518.611	USD -25,931	667.74 Profit of 7,457 on sale
2025-06-16	SELL	-312	522.680	538.200	536.648	USD -167,434	670.01 Profit of 41,609 on sale
2025-06-13	SELL	-1,278	529.240	529.550	529.519	USD -676,725	671.07 Profit of 180,900 on sale
2025-06-12	SELL	-1,151	521.840	525.220	524.882	USD -604,139	672.20 Profit of 169,562 on sale
2025-06-11	SELL	-52	518.600	528.370	527.393	USD -27,424	673.37 Profit of 7,591 on sale
2025-06-06	BUY	78	493.220	499.880	499.214	USD 38,939	677.17
2025-06-05	BUY	104	483.070	491.770	490.900	USD 51,054	678.69
2025-05-28	SELL	-78	591.850	606.000	604.585	USD -47,158	686.31 Profit of 6,374 on sale
2025-05-27	BUY	78	603.260	608.170	607.679	USD 47,399	687.00
2025-05-23	SELL	-234	588.340	591.640	591.310	USD -138,367	688.67 Profit of 22,782 on sale
2025-05-22	BUY	52	596.850	605.500	604.635	USD 31,441	689.46
2025-05-20	BUY	234	614.790	615.450	615.384	USD 144,000	690.84
2025-05-16	BUY	99	594.320	595.190	595.103	USD 58,915	692.53
2025-05-15	BUY	100	584.990	585.260	585.233	USD 58,523	693.49
2025-05-14	SELL	-675	571.360	580.560	579.640	USD -391,257	694.59 Profit of 77,593 on sale
2025-05-13	BUY	50	574.160	575.050	574.961	USD 28,748	695.69
2025-05-12	BUY	125	575.630	577.990	577.754	USD 72,219	696.79
2025-05-09	SELL	-100	527.780	552.840	550.334	USD -55,033	698.35 Profit of 14,802 on sale
2025-05-08	BUY	75	547.670	552.570	552.080	USD 41,406	699.76
2025-05-07	SELL	-125	560.930	568.130	567.410	USD -70,926	701.07 Profit of 16,708 on sale
2025-04-30	SELL	-25	598.760	600.200	600.056	USD -15,001	706.51 Profit of 2,661 on sale
2025-04-28	SELL	-150	610.860	614.830	614.433	USD -92,165	708.86 Profit of 14,164 on sale
2025-04-23	BUY	25	587.850	603.770	602.178	USD 15,054	712.37
2025-04-15	BUY	325	557.910	575.200	573.471	USD 186,378	722.30
2025-04-14	BUY	50	571.060	574.720	574.354	USD 28,718	723.99
2025-04-09	SELL	-150	576.720	580.730	580.329	USD -87,049	729.75 Profit of 22,413 on sale
2025-04-08	BUY	75	556.810	586.030	583.108	USD 43,733	731.78
2025-04-04	BUY	150	573.450	612.990	609.036	USD 91,355	735.60
2025-04-02	BUY	73	625.600	628.000	627.760	USD 45,826	736.95
2025-04-01	SELL	-225	617.000	641.240	638.816	USD -143,734	738.43 Profit of 22,412 on sale
2025-03-31	BUY	1,184	634.230	640.720	640.071	USD 757,844	739.73
2025-03-28	BUY	150	637.360	642.970	642.409	USD 96,361	741.03
2025-03-27	BUY	294	635.830	643.430	642.670	USD 188,945	742.37
2025-03-26	BUY	748	640.140	644.000	643.614	USD 481,423	743.70
2025-03-25	BUY	513	634.140	662.570	659.727	USD 338,440	745.14
2025-03-24	SELL	-75	661.000	667.460	666.814	USD -50,011	746.26 Profit of 5,959 on sale
2025-03-21	SELL	-4,100	658.480	661.000	660.748	USD -2,709,067	747.45 Profit of 355,483 on sale
2025-03-19	BUY	91	672.360	674.570	674.349	USD 61,366	749.67
2025-03-17	SELL	-188	678.420	679.830	679.689	USD -127,782	751.90 Profit of 13,576 on sale
2025-03-14	SELL	-94	666.870	686.980	684.969	USD -64,387	753.13 Profit of 6,407 on sale
2025-03-13	SELL	-94	680.610	698.950	697.116	USD -65,529	754.20 Profit of 5,366 on sale
2025-03-12	SELL	-188	689.500	712.460	710.164	USD -133,511	755.16 Profit of 8,460 on sale
2025-03-07	BUY	282	707.510	729.750	727.526	USD 205,162	756.65
2025-02-28	BUY	282	698.740	708.580	707.596	USD 199,542	761.32
2025-02-26	BUY	376	706.940	721.410	719.963	USD 270,706	763.27
2025-02-21	BUY	564	700.330	704.080	703.705	USD 396,890	766.05
2025-02-18	BUY	188	680.000	689.950	688.955	USD 129,524	770.59
2025-02-11	BUY	470	665.460	680.790	679.257	USD 319,251	781.28
2025-02-07	BUY	188	710.000	731.420	729.278	USD 137,104	784.88
2025-02-06	BUY	94	722.070	734.270	733.050	USD 68,907	786.31
2025-02-05	BUY	282	716.720	729.250	727.997	USD 205,295	787.93
2025-02-04	BUY	94	697.050	709.980	708.687	USD 66,617	790.09
2025-01-31	SELL	-188	672.980	688.000	686.498	USD -129,062	796.10 Profit of 20,605 on sale
2025-01-29	SELL	-188	687.270	697.570	696.540	USD -130,950	801.94 Profit of 19,815 on sale
2025-01-02	SELL	-557	715.190	726.810	725.648	USD -404,186	818.70 Profit of 51,829 on sale
2024-12-10	SELL	-94	778.500	791.490	790.191	USD -74,278	819.95 Profit of 2,798 on sale
2024-12-09	SELL	-94	788.000	800.990	799.691	USD -75,171	820.98 Profit of 2,002 on sale
2024-11-27	SELL	-188	754.870	762.160	761.431	USD -143,149	842.54 Profit of 15,249 on sale
2024-11-21	SELL	-376	744.500	757.560	756.254	USD -284,352	862.81 Profit of 40,066 on sale
2024-11-20	SELL	-188	743.350	750.690	749.956	USD -140,992	869.45 Profit of 22,465 on sale
2024-11-18	SELL	-188	762.000	762.700	762.630	USD -143,374	883.97 Profit of 22,812 on sale
2024-11-12	SELL	-564	821.000	831.000	830.000	USD -468,120	888.17 Profit of 32,806 on sale
2024-11-08	SELL	-1,504	828.420	830.730	830.499	USD -1,249,070	892.43 Profit of 93,151 on sale
2024-11-07	SELL	-658	824.480	832.530	831.725	USD -547,275	897.66 Profit of 43,386 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)
Issuer	Blackrock
Entity holding fund	iShares VI Public Limited Company
Entity Type
Entity LEI	549300VML6THE3JJOS76
ETF Ticker	SPMD(USD) LSE
ETF Ticker	SPMD.LS(USD) CXE
ETF Ticker	SPMD.L(GBP) LSE